Rising Demand for Japan Tuberculosis Diagnosis and Treatment Market Key Players, Growth Analysis during 2019-2025

Japan tuberculosis diagnosis and treatment market is anticipated to grow at a CAGR around 1.2% during the forecast period. Public health centers in Japan are local government authorities responsible for public health in Japan. Their responsibilities included recommendation to admit infectious TB patients to an isolation ward. Additionally, it included health checkups with chest X-ray of those in a close contact with infectious TB patients. Moreover, public subsidy of medical expenses for TB treatments facing the emergence of multi-drug resistant tuberculosis (MDR-TB) was the part of it. Furthermore, when compared to other countries such as US where the rate is 3.1, 4.7 in Canada, and 5.5 in the Netherlands and 5.9 in Sweden, Japan is still considered as a medium-burden tuberculosis country. Being a medium-burden tuberculosis country, high demand of diagnosis and treatment motivates the market in the country. Moreover, Otsuka, one of the key players in Japan known for developing drugs discovered and developed a new drug, delamanid that has demonstrated its efficacy against multidrug-resistant Mycobacterium tuberculosis (MDR-TB).

To Request a Sample of our Report on Japan Tuberculosis Diagnosis and Treatment Market:  https://www.omrglobal.com/request-sample/japan-tuberculosis-diagnosis-treatment-market

Japan tuberculosis diagnosis and treatment market is segmented on the basis of drugs type and diagnosis. Based on drug type, the market is segmented into first line drugs and second line drugs. Based on diagnosis, the market is segmented into laboratory testing, nucleic acid amplification test, mantoux test, radiography and drug susceptibility testing.

(Get 15% Discount on Buying this Report)

A full Report of Japan Tuberculosis Diagnosis and Treatment Market is Available @  https://www.omrglobal.com/industry-reports/japan-tuberculosis-diagnosis-treatment-market

Japan Tuberculosis Diagnosis and Treatment Market Segmentation

By Drugs Type

  • First Line Drugs
  • Second Line Drugs

By Diagnosis

  • Laboratory Testing
  • Nucleic Acid Amplification Test
  • Mantoux Test
  • Radiography
  • Drug Susceptibility Testing

Company Profiles

  • Abbott Laboratories
  • Becton, Dickinson and Co.
  • Biochemical and Synthetic Products Pvt Ltd.
  • Eiken Chemical Co., Ltd.
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline PLC
  • Labatec Pharma SA
  • Lupin Pharmaceuticals, Inc.
  • Otsuka Pharmaceutical Co, Ltd.
  • Thermo Fisher Scientific

Reasons to buy from us –

  1. We cover more than 15 major industries, further segmented into more than 90 sectors.
  2. More than 120 countries are for analysis.
  3. Over 100+ paid data sources mined for investigation.
  4. Our expert research analysts answer all your questions before and after purchasing your report.

About Orion Market Research 

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no:  +91 7803040404